185 related articles for article (PubMed ID: 17289026)
1. Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus.
Deshpande LS; Blair RE; Nagarkatti N; Sombati S; Martin BR; DeLorenzo RJ
Exp Neurol; 2007 Apr; 204(2):705-13. PubMed ID: 17289026
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.
Deshpande LS; Sombati S; Blair RE; Carter DS; Martin BR; DeLorenzo RJ
Neurosci Lett; 2007 Jan; 411(1):11-6. PubMed ID: 17110038
[TBL] [Abstract][Full Text] [Related]
3. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus.
Blair RE; Deshpande LS; Sombati S; Falenski KW; Martin BR; DeLorenzo RJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1072-8. PubMed ID: 16469864
[TBL] [Abstract][Full Text] [Related]
4. Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy.
Blair RE; Deshpande LS; Sombati S; Elphick MR; Martin BR; DeLorenzo RJ
Neuropharmacology; 2009 Sep; 57(3):208-18. PubMed ID: 19540252
[TBL] [Abstract][Full Text] [Related]
5. WIN 55,212-2 Reverted Pilocarpine-Induced Status Epilepticus Early Changes of the Interaction among 5-HT
Di Maio R; Colangeli R; Di Giovanni G
ACS Chem Neurosci; 2019 Jul; 10(7):3296-3306. PubMed ID: 30912644
[TBL] [Abstract][Full Text] [Related]
6. Inverse relationship of cannabimimetic (R+)WIN 55, 212 on behavior and seizure threshold during the juvenile period.
Rudenko V; Rafiuddin A; Leheste JR; Friedman LK
Pharmacol Biochem Behav; 2012 Jan; 100(3):474-84. PubMed ID: 22019959
[TBL] [Abstract][Full Text] [Related]
7. Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats.
Di Maio R; Cannon JR; Greenamyre JT
Neurobiol Dis; 2015 Jan; 73():356-65. PubMed ID: 25447228
[TBL] [Abstract][Full Text] [Related]
8. Acetaminophen inhibits status epilepticus in cultured hippocampal neurons.
Deshpande LS; DeLorenzo RJ
Neuroreport; 2011 Jan; 22(1):15-8. PubMed ID: 21037491
[TBL] [Abstract][Full Text] [Related]
9. CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2.
Németh B; Ledent C; Freund TF; Hájos N
Neuropharmacology; 2008 Jan; 54(1):51-7. PubMed ID: 17714744
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in the cannabinoid modulation of an A-type K+ current in neurons of the mammalian hypothalamus.
Tang SL; Tran V; Wagner EJ
J Neurophysiol; 2005 Oct; 94(4):2983-6. PubMed ID: 15901756
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices.
Mendiguren A; Pineda J
Neurosci Lett; 2004 Jun; 363(1):1-5. PubMed ID: 15157983
[TBL] [Abstract][Full Text] [Related]
12. Phosphatase inhibition prevents the activity-dependent trafficking of GABAA receptors during status epilepticus in the young animal.
Joshi S; Rajasekaran K; Hawk KM; Brar J; Ross BM; Tran CA; Chester SJ; Goodkin HP
Epilepsia; 2015 Sep; 56(9):1355-65. PubMed ID: 26248944
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity.
Shoshan N; Segev A; Abush H; Mizrachi Zer-Aviv T; Akirav I
Hippocampus; 2017 Oct; 27(10):1093-1109. PubMed ID: 28667676
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses.
Ohno-Shosaku T; Tsubokawa H; Mizushima I; Yoneda N; Zimmer A; Kano M
J Neurosci; 2002 May; 22(10):3864-72. PubMed ID: 12019305
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit.
Ganon-Elazar E; Akirav I
Psychoneuroendocrinology; 2013 Sep; 38(9):1675-87. PubMed ID: 23433741
[TBL] [Abstract][Full Text] [Related]
16. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons.
Pistis M; Perra S; Pillolla G; Melis M; Muntoni AL; Gessa GL
Biol Psychiatry; 2004 Jul; 56(2):86-94. PubMed ID: 15231440
[TBL] [Abstract][Full Text] [Related]
17. Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons.
Hampson RE; Simeral JD; Kelly EJ; Deadwyler SA
Hippocampus; 2003; 13(5):543-56. PubMed ID: 12921345
[TBL] [Abstract][Full Text] [Related]
18. Alterations of GABA A-receptor function and allosteric modulation during development of status epilepticus.
Feng HJ; Mathews GC; Kao C; Macdonald RL
J Neurophysiol; 2008 Mar; 99(3):1285-93. PubMed ID: 18216225
[TBL] [Abstract][Full Text] [Related]
19. Early polytherapy for benzodiazepine-refractory status epilepticus.
Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG
Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007
[TBL] [Abstract][Full Text] [Related]
20. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]